CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $48,000 | -85.5% | 11,011 | -47.6% | 0.01% | -84.2% |
| Q4 2015 | $330,000 | +34.7% | 21,014 | +139.1% | 0.06% | +7.5% |
| Q1 2015 | $245,000 | -41.9% | 8,788 | -62.0% | 0.05% | -55.5% |
| Q4 2014 | $422,000 | +108.9% | 23,114 | +48.2% | 0.12% | +158.7% |
| Q3 2014 | $202,000 | – | 15,601 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |